Displaying 1 - 4 of 4
  • Print
Contract Number Brand Code Brand Name Active Ingredient Trade Name Package Size Formulary Category Pkg Price Unit Price Unit Description Max. Reimbursable Quantity / Month Package Description Manufacturer Code Manufacturer Name Agent Code Agent Name Benefit Therapeutic Code Therapeutic Desc Drug Contract Start Date Drug Contract End Date Status Description Default Route Max Repeats Therapeutic Head Amend Date
40 4331G TASIGNA 150MG CAP (NVS/COL) NILOTANIB NILOTINIB TASIGNA 112'S C 11,490.9 102.60 CAPSULE 0 CAP NVS NOVARTIS CARIBE SA COL COLLINS LTD 1000 ANTINEOPLASTICS 2022-04-01 2024-03-31 Oral 0 ANTINEOPLASTICS
41 4331G TASIGNA 150MG CAP (NVS) NILOTANIB (BQ) NILOTINIB TASIGNA 112'S BQ 7611.31 67.9581 CAP 0 BOX NVS NOVARTIS CARIBE SA COL COLLINS LTD 1000 ANTINEOPLASTICS 2024-04-01 2026-03-31 ORAL 0 ANTINEOPLASTICS
40 4332B TASIGNA 200MG CAP (NVS/COL) NILOTANIB NILOTINIB TASIGNA 112'S C 13,233.8 118.16 CAPSULE 0 CAP NVS NOVARTIS CARIBE SA COL COLLINS LTD 1000 ANTINEOPLASTICS 2022-04-01 2024-03-31 Oral 0 ANTINEOPLASTICS
41 4332B TASIGNA 200MG CAP (NVS) NILOTANIB (BQ) NILOTINIB TASIGNA 112'S BQ 10329.63 92.2288 CAP 0 BOX NVS NOVARTIS CARIBE SA COL COLLINS LTD 1000 ANTINEOPLASTICS 2024-04-01 2026-03-31 ORAL 0 ANTINEOPLASTICS